We are live on ! Find out more
Assenagon Asset Management

Assenagon Asset Management Portfolio holdings

AUM $80.2B
1-Year Est. Return 50.57%
This Fund
S&P 500
This Quarter Est. Return
+12.27%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
AUM
$15.9B
AUM Growth
+$961M
Cap. Flow
-$622M
Cap. Flow %
-3.91%
Top 10 Hldgs %
35.94%
Holding
1,046
New
237
Increased
269
Reduced
219
Closed
304

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$654M
2
AGN
Allergan plc
AGN
+$320M
3
VZ icon
Verizon
VZ
+$255M
4
INTC icon
Intel
INTC
+$231M
5
CELG
Celgene Corp
CELG
+$224M

Sector Composition

Rank Sector Weight
1 Technology 14.12%
2 Communication Services 9.99%
3 Consumer Discretionary 8.74%
4 Healthcare 8.31%
5 Industrials 6.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHM icon
701
Autohome
ATHM
$2.62B
$304K ﹤0.01%
3,800
+900
+31% +$70.1K
IEX icon
702
IDEX
IEX
$17.3B
$292K ﹤0.01%
+1,696
New +$274K
VIPS icon
703
Vipshop
VIPS
$7.53B
$282K ﹤0.01%
+19,900
New +$236K
MG icon
704
Mistras Group
MG
$512M
$281K ﹤0.01%
19,689
-10,577
-35% -$150K
KMX icon
705
CarMax
KMX
$8.26B
$279K ﹤0.01%
+3,187
New +$300K
BABA icon
706
Alibaba
BABA
$308B
$276K ﹤0.01%
1,300
-200
-13% -$37.5K
EXTN
707
DELISTED
Exterran Corporation
EXTN
$276K ﹤0.01%
+35,294
New +$328K
OVID icon
708
Ovid Therapeutics
OVID
$491M
$274K ﹤0.01%
+65,906
New +$208K
AXTI icon
709
AXT Inc
AXTI
$5.8B
$271K ﹤0.01%
+62,218
New +$200K
RIGL icon
710
Rigel Pharmaceuticals
RIGL
$750M
$271K ﹤0.01%
12,673
-49,327
-80% -$1.02M
FFG
711
DELISTED
FBL Financial Group
FFG
$270K ﹤0.01%
+4,583
New +$264K
HSII
712
DELISTED
Heidrick & Struggles
HSII
$269K ﹤0.01%
8,271
-77,092
-90% -$2.27M
HTO
713
H2O America
HTO
$2.62B
$268K ﹤0.01%
+3,774
New +$267K
SPWR
714
DELISTED
SunPower Corporation Common Stock
SPWR
$265K ﹤0.01%
+51,794
New +$288K
BCRX icon
715
BioCryst Pharmaceuticals
BCRX
$2.4B
$258K ﹤0.01%
+74,744
New +$188K
DIOD icon
716
Diodes
DIOD
$4.84B
$258K ﹤0.01%
+4,572
New +$212K
EDU icon
717
New Oriental
EDU
$8.98B
$255K ﹤0.01%
+2,103
New +$251K
EW icon
718
Edwards Lifesciences
EW
$51.7B
$255K ﹤0.01%
3,285
-26,556
-89% -$2.07M
HSTM icon
719
HealthStream
HSTM
$840M
$254K ﹤0.01%
9,347
-29,851
-76% -$821K
CNS icon
720
Cohen & Steers
CNS
$4.3B
$244K ﹤0.01%
+3,885
New +$246K
BPMC
721
DELISTED
Blueprint Medicines
BPMC
$239K ﹤0.01%
+2,988
New +$224K
GEF icon
722
Greif
GEF
$5.04B
$237K ﹤0.01%
+5,356
New +$222K
MOMO
723
Hello Group
MOMO
$866M
$231K ﹤0.01%
+6,900
New +$245K
KLIC icon
724
Kulicke & Soffa
KLIC
$4.78B
$213K ﹤0.01%
+7,829
New +$193K
LHCG
725
DELISTED
LHC Group LLC
LHCG
$212K ﹤0.01%
+1,541
New +$192K

Similar funds

Assenagon Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Assenagon Asset Management held 1,046 positions worth $15.9B, up 6.4% from $14.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Assenagon Asset Management withdrew a net $622M in Q4 2019, closing 304 positions and reducing 219 holdings. Its most notable exit was Celgene Corp, an estimated $224M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 18% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Assenagon Asset Management opened a new position in RTX Corp worth $111M.

  • Assenagon Asset Management's largest Q4 2019 buy was RTX Corp: 1,174,659 shares worth $111M.
  • Assenagon Asset Management added most to Linde in Q4 2019, an estimated $326M increase.
  • Assenagon Asset Management's biggest Q4 2019 reduction was Microsoft, cutting an estimated $654M.
  • Assenagon Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $224M.
  • Assenagon Asset Management's ten largest holdings make up 36% of its $15.9B portfolio in Q4 2019.
  • Assenagon Asset Management opened 237 new positions and closed 304 in Q4 2019.
  • Assenagon Asset Management's portfolio value rose 6.4% quarter-over-quarter to $15.9B.

Based on Assenagon Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.